.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Julphar
Colorcon
US Department of Justice
Johnson and Johnson
Deloitte
AstraZeneca
McKinsey
Teva
Farmers Insurance

Generated: September 23, 2017

DrugPatentWatch Database Preview

Labetalol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for labetalol hydrochloride and what is the scope of labetalol hydrochloride patent protection?

Labetalol hydrochloride
is the generic ingredient in three branded drugs marketed by West-ward Pharms Int, Par Form, Sandoz, Allied Pharma Inc, Cnty Line Pharms, Apothecon, Akorn Inc, Sebela Ireland Ltd, Watson Labs, Sagent Agila Llc, Hospira, Baxter Hlthcare Corp, Schering, Ivax Sub Teva Pharms, Teva, and Gland Pharma Ltd, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for labetalol hydrochloride. Thirty-two suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: labetalol hydrochloride

Tradenames:3
Patents:0
Applicants:16
NDAs:21
Drug Master File Entries: see list14
Suppliers / Packagers: see list32
Bulk Api Vendors: see list53
Clinical Trials: see list2,306
Patent Applications: see list742
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:labetalol hydrochloride at DailyMed

Pharmacology for Ingredient: labetalol hydrochloride

Tentative approvals for LABETALOL HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe5MG/MLINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075133-001Aug 3, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION075431-001Nov 29, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
Par Form
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL200908-001Jul 10, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Schering
NORMODYNE
labetalol hydrochloride
INJECTABLE;INJECTION018686-001Aug 1, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL074989-002Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
INJECTABLE;INJECTION075239-001Nov 29, 1999APRXNoYes► Subscribe► Subscribe► Subscribe
Apothecon
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075223-003Nov 20, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL074989-001Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075113-001Aug 4, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
LABETALOL HYDROCHLORIDE
labetalol hydrochloride
TABLET;ORAL075113-002Aug 4, 1998ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: labetalol hydrochloride

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Deloitte
US Department of Justice
Fish and Richardson
QuintilesIMS
McKesson
Moodys
Cerilliant
Farmers Insurance
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot